{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:50:55Z","timestamp":1792799455417,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T00:00:00Z","timestamp":1761264000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]},{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]},{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]},{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]},{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]},{"name":"Jeffrey Cheah School of Medicine and Health Sciences (JCSMHS) Seed Grant 2023, Monash University Malaysia","award":["I-M010-SED-000 173"],"award-info":[{"award-number":["I-M010-SED-000 173"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Ment Health"],"DOI":"10.1007\/s44192-025-00254-x","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:08:27Z","timestamp":1761300507000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Modulation of NF-\u03baB signaling pathway by tocotrienol in neurodegenerative diseases"],"prefix":"10.1007","volume":"5","author":[{"given":"Shin Yii","family":"Ang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saatheeyavaane","family":"Bhuvanendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa Lin Lin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Yi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammu K.","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaarvena","family":"Retinasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,24]]},"reference":[{"issue":"1","key":"254_CR1","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W, et al. Role of neuroinflammation in neurodegeneration development. Signal Trans Target Therapy. 2023;8(1):267.","journal-title":"Signal Trans Target Therapy"},{"issue":"3\u20134","key":"254_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000535683","volume":"23","author":"M Alonso-Sard\u00f3n","year":"2023","unstructured":"Alonso-Sard\u00f3n M, et al. epidemiological impact of neurodegenerative diseases in the rural spanish-portuguese cross-border region. Neurodegener Dis. 2023;23(3\u20134):25\u201334.","journal-title":"Neurodegener Dis"},{"issue":"20","key":"254_CR3","doi-asserted-by":"publisher","first-page":"e202300225","DOI":"10.1002\/slct.202300225","volume":"8","author":"S Zaib","year":"2023","unstructured":"Zaib S, Javed H, Khan I, Jaber F, Sohail A, Zaib Z, Ogaly HA. Neurodegenerative diseases: their onset, epidemiology, causes and treatment. ChemistrySelect. 2023;8(20):e202300225.","journal-title":"ChemistrySelect"},{"key":"254_CR4","doi-asserted-by":"crossref","unstructured":"Carmen Pe\u00f1a-Bautista ECF, M\u00e1ximo V, Miguel B, Consuelo CP. Stress and neurodegeneration. Clin Chim Acta. 2020;503.","DOI":"10.1016\/j.cca.2020.01.019"},{"issue":"3","key":"254_CR5","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.3390\/ijms23031851","volume":"23","author":"RNL Lamptey","year":"2022","unstructured":"Lamptey RNL, et al. A review of the common neurodegenerative disorders: current therapeutic approaches and the potential role of nanotherapeutics. Int J Mol Sci. 2022;23(3):1851.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"254_CR6","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1007\/s41019-016-0011-3","volume":"1","author":"S Siuly","year":"2016","unstructured":"Siuly S, et al. Medical big data: neurological diseases diagnosis through medical data analysis. Data Sci Eng. 2016;1(2):54\u201364.","journal-title":"Data Sci Eng"},{"issue":"10","key":"254_CR7","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3390\/ijms17101745","volume":"17","author":"F Shahidi","year":"2016","unstructured":"Shahidi F, De Camargo AC. Tocopherols and tocotrienols in common and emerging dietary sources: occurrence, applications, and health benefits. Int J Mol Sci. 2016;17(10):1745.","journal-title":"Int J Mol Sci"},{"key":"254_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s00210-025-03888-4","author":"M Faysal","year":"2025","unstructured":"Faysal M, et al. Therapeutic potential of flavonoids in neuroprotection: brain and spinal cord injury focus. Naunyn-Schmiedebergs Arch Pharmacol. 2025. https:\/\/doi.org\/10.1007\/s00210-025-03888-4.","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"254_CR9","doi-asserted-by":"publisher","DOI":"10.2147\/DNND.S452009","author":"PN Tripathi","year":"2024","unstructured":"Tripathi PN, et al. Review of pharmacotherapeutic targets in Alzheimer\u2019s disease and its management using traditional medicinal plants. Degener Neurol Neuromuscul Dis. 2024. https:\/\/doi.org\/10.2147\/DNND.S452009.","journal-title":"Degener Neurol Neuromuscul Dis"},{"key":"254_CR10","doi-asserted-by":"publisher","first-page":"754086","DOI":"10.3389\/fnut.2021.754086","volume":"8","author":"R Naomi","year":"2021","unstructured":"Naomi R, et al. An interactive review on the role of tocotrienols in the neurodegenerative disorders. Front Nutr. 2021;8:754086.","journal-title":"Front Nutr"},{"issue":"10","key":"254_CR11","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1016\/j.neurobiolaging.2011.11.019","volume":"33","author":"WX Francesca Mangialasche","year":"2012","unstructured":"Francesca Mangialasche WX, Kivipelto M, Costanzi E, Ercolani S, Pigliautile M, Cecchetti R, Baglioni M, Simmons A, Soininen H, Tsolaki M, Kloszewska I, Vellas B, Lovestone S, Mecocci P. Tocopherols and tocotrienols plasma levels are associated with cognitive impairment. Neurobiol Aging. 2012;33(10):2282\u201390.","journal-title":"Neurobiol Aging"},{"key":"254_CR12","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.131863.1","author":"AM Mathew","year":"2023","unstructured":"Mathew AM, et al. Exploring the anti-inflammatory activities, mechanism of action and prospective drug delivery systems of tocotrienol to target neurodegenerative diseases. F1000Res. 2023. https:\/\/doi.org\/10.12688\/f1000research.131863.1.","journal-title":"F1000Res"},{"issue":"16","key":"254_CR13","doi-asserted-by":"publisher","first-page":"8972","DOI":"10.3390\/ijms23168972","volume":"23","author":"E Sun","year":"2022","unstructured":"Sun E, et al. The pivotal role of NF-kB in the pathogenesis and therapeutics of Alzheimer\u2019s disease. Int J Mol Sci. 2022;23(16):8972.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"254_CR14","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1172\/JCI11916","volume":"107","author":"MP Mattson","year":"2001","unstructured":"Mattson MP, Camandola S. NF-\u03baB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 2001;107(3):247\u201354.","journal-title":"J Clin Invest"},{"key":"254_CR15","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.11.2.123","author":"S Camandola","year":"2007","unstructured":"Camandola S, Mattson MP. NF-\u03baB as a therapeutic target in neurodegenerative diseases. Expert Opin Ther Targets. 2007. https:\/\/doi.org\/10.1517\/14728222.11.2.123.","journal-title":"Expert Opin Ther Targets"},{"issue":"1","key":"254_CR16","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND. Integrating cell-signalling pathways with NF-\u03baB and IKK function. Nat Rev Mol Cell Biol. 2007;8(1):49\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"254_CR17","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/nrm2083","volume":"8","author":"ND Perkins","year":"2007","unstructured":"Perkins ND. Integrating cell-signalling pathways with NF-\u03baB and IKK function. Nat Rev Mole Cell Biol. 2007;8(1):49\u201362.","journal-title":"Nat Rev Mole Cell Biol"},{"issue":"1","key":"254_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.4049\/jimmunol.1403149","volume":"195","author":"Y Wang","year":"2015","unstructured":"Wang Y, et al. Vitamin E \u03b3-tocotrienol inhibits cytokine-stimulated NF-\u03baB activation by induction of anti-inflammatory A20 via stress adaptive response due to modulation of sphingolipids. J Immunol. 2015;195(1):126\u201333.","journal-title":"J Immunol"},{"key":"254_CR19","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200207120949","author":"S Singh","year":"2020","unstructured":"Singh S, Singh TG. Role of nuclear factor kappa B (NF-KB) signalling in neurodegenerative diseases: an mechanistic approach. Curr Neuropharmacol. 2020. https:\/\/doi.org\/10.2174\/1570159X18666200207120949.","journal-title":"Curr Neuropharmacol"},{"key":"254_CR20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.021908.132641","author":"S Vallabhapurapu","year":"2009","unstructured":"Vallabhapurapu S, et al. Regulation and function of NF-\u03baB transcription factors in the immune system. Annu Rev Immunol. 2009. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132641.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"254_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s12035-013-8595-3","volume":"50","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ. Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer\u2019s disease (AD) and in primary human neuronal-glial (HNG) cells. Mol Neurobiol. 2014;50(1):97\u2013106.","journal-title":"Mol Neurobiol"},{"key":"254_CR22","doi-asserted-by":"publisher","first-page":"148603","DOI":"10.1016\/j.brainres.2023.148603","volume":"1822","author":"J Song","year":"2024","unstructured":"Song J, Zhao Y, Shan X, Luo Y, Hao N, Zhao L. Active ingredients of Chinese medicine with immunomodulatory properties: NF-\u03baB pathway and Parkinson\u2019s disease. Brain Res. 2024;1822:148603.","journal-title":"Brain Res"},{"key":"254_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01043","author":"EC Dresselhaus","year":"2019","unstructured":"Dresselhaus EC, Meffert MK. Cellular specificity of NF-\u03baB function in the nervous system. Front Immunol. 2019. https:\/\/doi.org\/10.3389\/fimmu.2019.01043.","journal-title":"Front Immunol"},{"issue":"7","key":"254_CR24","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1080\/00207454.2016.1212854","volume":"127","author":"T Shabab","year":"2017","unstructured":"Shabab T, et al. Neuroinflammation pathways: a general review. Int J Neurosci. 2017;127(7):624\u201333.","journal-title":"Int J Neurosci"},{"issue":"2","key":"254_CR25","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1096\/fj.03-0961fje","volume":"18","author":"S Sung","year":"2004","unstructured":"Sung S, Yao Y, Uryu K, Yang H, Lee VMY, Trojanowski JQ, Pratic\u00f2 D. Early vitamin E supplementation in young but not aged mice reduces A\u03b2 levels and amyloid deposition in a transgenic model of Alzheimer\u2019s disease. FASEB J. 2004;18(2):323\u20135.","journal-title":"FASEB J"},{"issue":"5","key":"254_CR26","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.3390\/nu13051583","volume":"13","author":"M Kumari","year":"2021","unstructured":"Kumari M, Ramdas P, Radhakrishnan AK, Kutty MK, Haleagrahara N. Tocotrienols ameliorate neurodegeneration and motor deficits in the 6-OHDA-induced rat model of parkinsonism: behavioural and immunohistochemistry analysis. Nutrients. 2021;13(5):1583.","journal-title":"Nutrients"},{"issue":"4","key":"254_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.55230\/mabjournal.v51i4.23","volume":"51","author":"ABD Muid","year":"2022","unstructured":"Muid ABD, et al. Effects of palm oil derived tocotrienol rich fraction and vitamin e isomers on biomarkers of early atherogenesis in stimulated human umbilical vein endothelial cells. Malays Appl Biol. 2022;51(4):145\u201352.","journal-title":"Malays Appl Biol"},{"issue":"5","key":"254_CR28","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1161\/STROKEAHA.113.004449","volume":"45","author":"ILS Yogheswaran Gopalan","year":"2014","unstructured":"Yogheswaran Gopalan ILS, Magosso E, Ansari MA, Bakar MRA, Wong JW, Khan NAK, Liong WC, Sundram K, Ng BH, Karuthan C, Yuen KH. Clinical investigation of the protective effects of palm vitamin E tocotrienols on brain white matter. Stroke. 2014;45(5):1422\u20138.","journal-title":"Stroke"},{"issue":"11","key":"254_CR29","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.3390\/ijms17111682","volume":"17","author":"P Meganathan","year":"2016","unstructured":"Meganathan P, Fu JY. Biological properties of tocotrienols: evidence in human studies. Int J Mol Sci. 2016;17(11):1682.","journal-title":"Int J Mol Sci"},{"key":"254_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2007.03.001","author":"CK Sen","year":"2007","unstructured":"Sen CK, Khanna S, Roy S. Tocotrienols in health and disease: the other half of the natural vitamin E family. Mol Aspects Med. 2007. https:\/\/doi.org\/10.1016\/j.mam.2007.03.001.","journal-title":"Mol Aspects Med"},{"issue":"11","key":"254_CR31","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.bcp.2010.07.043","volume":"80","author":"BB Aggarwal","year":"2010","unstructured":"Aggarwal BB, et al. Tocotrienols, the vitamin E of the 21st century: Its potential against cancer and other chronic diseases. Biochem Pharmacol. 2010;80(11):1613\u201331.","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"254_CR32","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/1743-7075-11-52","volume":"11","author":"H Ahsan","year":"2014","unstructured":"Ahsan H, et al. Pharmacological potential of tocotrienols: a review. Nutr Metab. 2014;11(1):52.","journal-title":"Nutr Metab"},{"issue":"8","key":"254_CR33","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/mnfr.200700418","volume":"52","author":"SJ Wu","year":"2008","unstructured":"Wu SJ, Liu PL, Ng LT. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. Mol Nutr Food Res. 2008;52(8):921\u20139.","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"254_CR34","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1074\/jbc.M610028200","volume":"282","author":"KS Ahn","year":"2007","unstructured":"Ahn KS, et al. \u03b3-tocotrienol inhibits nuclear factor-\u03baB signaling pathway through inhibition of receptor-interacting protein and TAK1 leading to suppression of antiapoptotic gene products and potentiation of apoptosis. J Biol Chem. 2007;282(1):809\u201320.","journal-title":"J Biol Chem"},{"issue":"7","key":"254_CR35","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/BF02522884","volume":"31","author":"A Kamal-Eldin","year":"1996","unstructured":"Kamal-Eldin A, Appelqvist L\u00c5. The chemistry and antioxidant properties of tocopherols and tocotrienols. Lipids. 1996;31(7):671\u2013701.","journal-title":"Lipids"},{"issue":"1","key":"254_CR36","doi-asserted-by":"publisher","first-page":"259","DOI":"10.3390\/nu12010259","volume":"12","author":"SK Wong","year":"2020","unstructured":"Wong SK, et al. Potential role of tocotrienols on non-communicable diseases: a review of current evidence. Nutrients. 2020;12(1):259.","journal-title":"Nutrients"},{"issue":"2","key":"254_CR37","doi-asserted-by":"publisher","first-page":"369S","DOI":"10.1093\/jn\/131.2.369S","volume":"131","author":"L Packer","year":"2001","unstructured":"Packer L, Weber SU, Rimbach G. Molecular aspects of \u03b1-tocotrienol antioxidant action and cell signalling. J Nutr. 2001;131(2):369S-373S.","journal-title":"J Nutr"},{"issue":"4","key":"254_CR38","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/biof.1873","volume":"48","author":"R Ranasinghe","year":"2022","unstructured":"Ranasinghe R, Mathai M, Zulli A. Revisiting the therapeutic potential of tocotrienol. BioFactors. 2022;48(4):813\u201356.","journal-title":"BioFactors"},{"issue":"7","key":"254_CR39","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1007\/s12035-020-01945-y","volume":"57","author":"SN Rai","year":"2020","unstructured":"Rai SN, et al. Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer\u2019s disease. Mol Neurobiol. 2020;57(7):3075\u201388.","journal-title":"Mol Neurobiol"},{"issue":"7","key":"254_CR40","doi-asserted-by":"publisher","first-page":"881","DOI":"10.3390\/nu10070881","volume":"10","author":"KY Chin","year":"2018","unstructured":"Chin KY, Tay SS. A review on the relationship between tocotrienol and Alzheimer disease. Nutrients. 2018;10(7):881.","journal-title":"Nutrients"},{"issue":"2","key":"254_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1172\/JCI11914","volume":"107","author":"Y Yamamoto","year":"2001","unstructured":"Yamamoto Y, Gaynor RB. Therapeutic potential of inhibition of the NF-\u03baB pathway in the treatment of inflammation and cancer. J Clin Invest. 2001;107(2):135\u201342.","journal-title":"J Clin Invest"},{"issue":"10","key":"254_CR42","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.3390\/ph16101403","volume":"16","author":"NV Mohamad","year":"2023","unstructured":"Mohamad NV. Strategies to enhance the solubility and bioavailability of tocotrienols using self-emulsifying drug delivery system. Pharmaceuticals. 2023;16(10):1403.","journal-title":"Pharmaceuticals"},{"key":"254_CR43","doi-asserted-by":"crossref","unstructured":"Zaffarin ASM et al. Pharmacology and pharmacokinetics of vitamin E: nanoformulations to enhance bioavailability. Int J Nanomed. 2020;15.","DOI":"10.2147\/IJN.S276355"}],"container-title":["Discover Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-025-00254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44192-025-00254-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44192-025-00254-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:08:29Z","timestamp":1761300509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44192-025-00254-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1007\/s44192-025-00254-x","relation":{},"ISSN":["2731-4383"],"issn-type":[{"value":"2731-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,24]]},"assertion":[{"value":"13 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"160"}}